Quantcast
Last updated on April 20, 2014 at 7:48 EDT

Latest Inhaler Stories

2009-09-16 07:10:00

VIENNA, Sept. 16 /PRNewswire/ -- Teva Respiratory, a division of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), today announced results from an analysis of the cost-effectiveness of three different inhaled corticosteroids (ICSs) in a "real-life" asthmatic population. The study found QVAR(R) (beclomethasone dipropionate HFA), an ICS that is able to effectively treat both large and small airway inflammation, to be on average more effective than CFC-beclomethasone dipropionate (BDP) and...

2009-09-08 12:51:00

LOURES, Portugal, September 8 /PRNewswire/ -- Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co. Ltd. (Tokyo, Japan) and Biota Holdings Ltd (Victoria, Australia) have both announced successful Phase III trials for CS-8958, a new long-acting neuraminidase inhibitor for treatment of influenza (known as a prodrug of laninamivir). CS-8958, co-owned by Daiichi Sankyo and Biota, is delivered by TwinCaps(R), a patented dry powder inhaler which Hovione...

2009-08-24 15:30:00

RESEARCH TRIANGLE PARK, N.C., Aug. 24 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) is advising that two lots of Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) medication were stolen on August 2 from the company's distribution facility near Richmond, Virginia. Medicine in the stolen cartons could represent a health risk because it has been removed from the legitimate supply chain and the storage conditions under which the stolen products were held are...

2009-08-19 09:00:00

The first dry powder inhalable vaccine for measles is moving toward clinical trials next year in India, where the disease still sickens millions of infants and children and kills almost 200,000 annually, according to a new report. Robert Sievers, Ph.D., who leads the team that developed the dry-powder vaccine noted that it is a perfect fit for use in back-roads areas of developing countries, which often lack clean water, sterile needles and the electricity for refrigeration that are all...

2009-08-12 10:42:11

U.S. medical scientists say they have identified an enzyme that might lead to a new and powerful therapy for most allergen-caused asthma attacks. Researchers at the University of Texas Medical Branch at Galveston said the enzyme (aldose reductase) is apparently critical to most allergen-provoked asthma attacks and that enzymatic activity can be significantly reduced by compounds that have already undergone clinical trials as treatments for complications of diabetes. The scientists said their...

2009-08-07 00:55:11

New laws in several U.S. states give children the right to self-administer medications for asthma, a health group says. Members of Allergy & Asthma Network Mothers of Asthmatics report schools are making changes to respond to new laws in Louisiana, Connecticut, Georgia and Pennsylvania that allow children to carry and use inhalers and auto-injectable epinephrine. Parents and pediatricians need to check if the students in their care are ready for this responsibility, AANMA members advise....

2009-07-22 15:35:00

KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Schering-Plough today announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed in the United States and accepted for review by the U.S. Food and Drug Administration (FDA). Schering-Plough is seeking marketing approval from the FDA of the mometasone furoate/formoterol fumarate combination for the maintenance treatment of asthma in patients 12 years of age and older....

2009-07-21 08:00:00

MIDLOTHIAN, Va., July 21 /PRNewswire/ -- Today, PARI Respiratory Equipment was granted a US Patent for its Vortex Holding Chamber, a unique, non-electrostatic, holding chamber with a one piece, dual-valve system that optimizes patient inhalation and exhalation for more efficient medication delivery with a metered dose inhaler (MDI). "While metered dose inhalers offer a quick burst of medication, there are a number of problems delivering an effective dose to patients. These include...

2009-07-10 15:01:33

Medications and lifestyle changes help manage asthma, but they will not actually cure it, according to an expert at Baylor College of Medicine (www.bcm.edu).  "You still have airway inflammation that needs to be treated," said Dr. Nicola Hanania (http://www.bcm.edu/medicine/pulmonary/?pmid=4506), associate professor of medicine at BCM.  Asthma affects about 24 million Americans and has a higher prevalence in the inner city population, said Hanania. Treatment for asthma depends on...

2009-07-09 15:06:00

KENILWORTH, N.J., July 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for ASMANEX TWISTHALER (mometasone furoate dry powder inhaler) for the treatment of bronchial asthma in adults.(1) "We are pleased to announce the approval of the ASMANEX TWISTHALER in Japan," said Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough...